Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus

Medicine & Life Sciences

• HDL Lipoproteins 83%
• Lipolysis 78%
• Fatty Acids 67%
• Type 2 Diabetes Mellitus 59%
• AMP-Activated Protein Kinases 53%
• Lipidomics 30%
• Nonesterified Fatty Acids 23%
• Insulin 23%
• Adipocytes 21%
• high density lipoprotein phosphatidylcholine 21%
• Fasting 18%
• 3T3-L1 Cells 13%
• Phospholipases 13%
• Glycerol 11%
• Hydrolysis 10%
• Cross-Over Studies 10%
• Mass Spectrometry 10%
• Phospholipids 10%
• In Vitro Techniques 9%
• Adipose Tissue 9%
• Fats 8%
• Placebos 7%
• Lipids 7%
• Glucose 7%
• Muscles 6%

Chemical Compounds

• High-Density Lipoprotein 100%
• Fatty Acid 63%
• Pharmacological Metabolism 60%
• Insulin Derivative 34%
• Plasma 20%
• Protein 18%
• Oxidation Reaction 15%
• Fat 11%
• Phosphatidylcholine 11%
• Glycerol 9%
• Phospholipid 9%
• Glucose 8%
• Lipid 7%
• Mass Spectrometry 7%
• Hydrolysis 6%
• Reduction 5%